Genetic abnormalities of vasopressin gene and evaluation of gene expression.
Genetic abnormalities of vasopressin gene and evaluation of gene expression.
批准号:
06671019
负责人:
OISO Yutaka
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Familial central diabetes insipidus (FDI) is an autosomal dominant disease caused by a deficiency of arginine vasopressin (AVP). We have previously reported 6 distinct mutations within the AVP gene encoding the AVP precursor in Japanese patients with FDI in the signal peptide region (A-1T), and the neurophysin region (E47del, G57S,G62W,G65V,C67stop). To study the pathogenesis of FDI,mouse corticotroph AtT20 cells were transfected with either wild-type or mutant human AVP cDNA.Transient transfection studies showed that the AVP immunoreactivity in culture media from cells transfected with each mutant AVP cDNA was markedly decreased compared to wild type (2 to 30%). In patients with AVP gene heterozygosity, one would expect AVP production from the normal allele to be sufficient in preventing diabetes insipidus. However, the disease manifests itself in an autosomal dominant manner. This suggestes that mutant AVP gene products may affect AVP secretion from the wild-type precursor. The potential dominant negative effect was examined in cotransfection experiments. However, the AVP immunoactivity in media obtained from AtT20 cells transiently co-transfected with wild-type and mutant AVP cDNAs was not altered. Further studies will be necessary to explain the sutosomal dominant nature of this disease.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yutaka Oiso et al.: "The Pituitary Gland,Second Edition," Raven Press,Ltd.,New York,1994, 13 (1994)
Yutaka Oiso 等:“垂体,第二版”,Raven Press, Ltd.,纽约,1994 年,13 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大磯ユタカ: "最近注目されている神経内分泌疾患:遺伝性尿崩症" ホルモンと臨床. 42. 1031-1036 (1994)
Yutaka Oiso:“最近引起关注的神经内分泌疾病:遗传性尿崩症”激素和临床研究 42. 1031-1036 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiromitsu Yuasa et al.: "Novel mutations in the V2 vasopressin receptor gene in two pedigrees with congenital nephrogenic diabetes insipidus." J.Clin.Endocrinol.Metab.79. 361-365 (1994)
Hiromitsu Yuasa 等人:“两个先天性肾性尿崩症家系中 V2 加压素受体基因的新突变。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takashi Murase et al.: "The expression of pituitary adenylate cyclase-activating polypeptide(PACAP)mRNA in rat brain:possible role of endogenous PACAP in vasopressin release." Neuroscience Letters. 185. 103-106 (1995)
Takashi Murase 等人:“大鼠脑中垂体腺苷酸环化酶激活多肽 (PACAP) mRNA 的表达:内源性 PACAP 在加压素释放中的可能作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiromitsu Yuasa et al.: "Novel mutations in the V2 vasopressin receptor gene in two pedigrees with congenital nephrogenic diabetes insipidus." J.Clin.Endocrional.Metab.79. 361-365 (1994)
Hiromitsu Yuasa 等人:“两个先天性肾性尿崩症家系中 V2 加压素受体基因的新突变。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Analysis of process from ER stress to cell death in an animal model for disease
-
批准号:23659475
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2011
-
负责人:OISO Yutaka
-
依托单位:
The regenerative therapy for central diabetes insipidus
-
批准号:22390188
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.99万
-
财政年份:2010
-
负责人:OISO Yutaka
-
依托单位:
Analysis of neural cell death using knock-in mouse model and organotypic culture system.
-
批准号:14370325
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.59万
-
财政年份:2002
-
负责人:OISO Yutaka
-
依托单位:
Physiological characterization of the human vasopressin transgenic rats.
-
批准号:08457263
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.8万
-
财政年份:1996
-
负责人:OISO Yutaka
-
依托单位:
Regulation and expression of vasopressin-neurophysin II gene.
-
批准号:03671142
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1991
-
负责人:OISO Yutaka
-
依托单位:
Effects of Opioid Peptides on the Regulation of Vasopressin Secretion.
-
批准号:01570633
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.9万
-
财政年份:1989
-
负责人:OISO Yutaka
-
依托单位:
海外基金